Today: 7 February 2026
Subscribe
Browse Category

Dividends News 28 October 2025 - 9 November 2025

ARCC Stock Today: Ares Capital’s 9.5% Dividend, Q3 Record NAV, and Fresh Insider Buying (Nov. 9, 2025)

ARCC Stock Today: Ares Capital’s 9.5% Dividend, Q3 Record NAV, and Fresh Insider Buying (Nov. 9, 2025)

What’s new on November 9, 2025 By the numbers — Ares Capital’s Q3 2025 snapshot Dividend watch: dates, yield and coverage Insider buying: why it matters CEO Kort Schnabel’s open‑market purchase—13,000 shares for $265,070—adds a tangible vote of confidence from the top. The Form 4 shows prices ranged $20.29–$20.49 on Oct. 31. Insider buys don’t guarantee performance, but they often support sentiment when paired with stable fundamentals and dividend coverage. SEC+1 Valuation check (today) What to watch next Media & analyst chatter you may have missed this week Bottom line For Nov. 9, 2025, the ARCC narrative remains income‑first with
9 November 2025
·
DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont (DD) Today: Citi Lifts Price Target to $47 as “New DuPont” Sets $0.20 Dividend, $2B Buyback After Qnity Spin

DuPont de Nemours, Inc. (NYSE: DD) headlines today with a fresh analyst target bump and continued investor focus on the company’s post‑spinoff profile, dividend reset, and buyback plans. Key takeaways What’s new today (Nov. 9, 2025) The bigger picture: A pivotal week for “new DuPont” Qnity Electronics is out; DuPont refocuses. DuPont completed the tax‑free separation of Qnity on Nov. 1 (1 share of Qnity for every 2 DD shares; ~209M Qnity shares distributed). Qnity began “regular‑way” trading on Nov. 3 as NYSE: Q and was added to the S&P 500 at launch—an unusual debut that broadens index fund ownership.
9 November 2025
·
PayPal (PYPL) Today — Nov. 9, 2025: Antitrust Win, Dividend Countdown, and AI Checkout Momentum

PayPal (PYPL) Today — Nov. 9, 2025: Antitrust Win, Dividend Countdown, and AI Checkout Momentum

What happened & why it matters 1) Legal overhang eases—again On Nov. 6, Judge Jeffrey S. White (N.D. Cal.) dismissed a proposed nationwide class action alleging PayPal’s merchant rules inflated online prices by preventing discounts for lower‑cost payment methods. The court found the complaint lacked sufficient allegations of market power and direct consumer harm—key elements for antitrust standing. The judge gave plaintiffs until Dec. 12, 2025 to amend. The ruling reinforces PayPal’s recent momentum in fending off similar claims. Reuters+1 2) Funds reposition around PYPL Two November 9 items from MarketBeat highlight institutional position reductions (King Luther Capital Management; Flossbach
9 November 2025
···
J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

NJ Stock: What to Know Before the Bell on November 10, 2025 (Fresh FDA Wins, Dividend Date, and Legal Overhang)

Dateline: Monday, November 10, 2025 — pre‑market Johnson & Johnson (NYSE: JNJ) starts the new week with momentum from multiple drug approvals, a firm dividend timetable, and a still‑active litigation backdrop. Here’s a concise, investor‑focused briefing on the key developments likely to guide JNJ sentiment before the U.S. market opens today. Key takeaways• Q3 beat and higher 2025 sales outlook; adjusted EPS guidance reaffirmed. JNJ.com+1• Two fresh FDA wins in the past few weeks: Caplyta add‑on use in depression and Darzalex Faspro for high‑risk smoldering myeloma. Reuters+1• Inlexzo bladder‑cancer device approval broadens 2025 product catalysts. U.S. Food and Drug Administration•
9 November 2025
·
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth (UNH) premarket: Dividend set, UBS talk at 8:45 a.m. ET, raised guidance — what to watch on November 10, 2025

Overview (as of Sunday, November 9, 2025)UnitedHealth Group (NYSE: UNH) starts the new week in the spotlight with a live interview at the UBS Global Healthcare Conference before the bell on Monday, alongside a fresh quarterly dividend declaration and a late-October guidance raise. Investors will be parsing any color on 2026 medical-cost trends, Medicare Advantage star ratings and policy tailwinds, ongoing DOJ matters, and integration updates after August’s Amedisys close. Centers for Medicare & Medicaid Services+3SEC+3UnitedHealth Group+3 Top overnight and recent headlines• Dividend: The board authorized a quarterly cash dividend of $2.21 per share, payable Dec. 16, 2025, to shareholders
9 November 2025
··
Mastercard Stock Climbs on New Tech, Stablecoin Push and Partnerships

Mastercard (MA) Today: Poland Hubs, Live Nation SA, Upward Deal, RS2 Issuing & Dividend — Nov 7, 2025

Published: Friday, November 7, 2025 Summary: Mastercard (NYSE: MA) made headlines today with an expansion of its professional services footprint in Poland, a new live‑entertainment partnership in South Africa, startup and issuer developments in embedded finance, and the payment of its quarterly dividend. Here’s everything investors, partners, and readers need to know. Key takeaways (Nov 7, 2025) Europe: new Professional Services Hubs in Poland Marking 30 years in Poland, Mastercard announced the development of Professional Services Hubs in Warsaw and Gdańsk to accelerate innovation across consulting, analytics, AI, cybersecurity and open finance. Warsaw plans to double its specialist workforce to
7 November 2025
·
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petróleo Brasileiro S.A. (Petrobras) shares are higher today after the company’s third‑quarter print, a fresh dividend announcement and upbeat commentary on its 2025 investment pace. By 19:25 UTC, U.S.-listed PBR ADRs traded around $12.71 (≈+4.7% on the day) and PBR.A near $11.92 (≈+3.0%). Brazilian preferreds PETR4 were also firmer in São Paulo around midday, at R$31.90 (≈+2.7%). InfoMoney Key takeaways What moved Petrobras stock today 1) Dividend details investors needed Petrobras’ board approved R$12.16bn in interim dividends for 2025, equal to R$0.94320755 per share for both common and preferred stock. Payments will be split into two tranches (Feb 20 and
7 November 2025
··
Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Pfizer (PFE) Stock Today — Nov 7, 2025: Metsera Bidding War Intensifies, Dividend Record Date, and What’s Moving the Share Price

Last updated: Nov 7, 2025 (19:23 UTC) Pfizer (NYSE: PFE) shares were trading around $24.28, down roughly 2.3% intraday, as investors weighed new twists in the Metsera takeover fight and marked today’s dividend record date. As of the latest print, the stock’s day range was $24.12–$24.61 on heavy volume. Key takeaways Pfizer stock price today (intraday) What changed today — Nov 7, 2025 1) Metsera bidding war heats up Why it matters: The Metsera outcome could reshape Pfizer’s cardiometabolic/obesity ambitions after earlier setbacks, and investors are repricing PFE daily on any signal of who ultimately wins—and at what cost. Financial
7 November 2025
··
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?

Saudi Aramco (2222.SR) — Before Market Open Today (Nov 7, 2025): Oil Rebounds But Heads for Weekly Loss, Aramco Cuts Asian OSPs, and Q3 Dividend Dates to Watch

Dateline: Friday, November 7, 2025 — Riyadh/Dhahran Note on timing: The Saudi Exchange (Tadawul) does not trade on Fridays. The next equity session opens Sunday, Nov 9, 10:00 a.m. KSA (pre‑open auction 9:30–10:00). Use today’s headlines to position for Sunday’s open. Tadawul Group Key takeaways Market backdrop today (Nov 7) Oil prices edged higher early Friday but remain on track for a second weekly decline amid inventory builds and lingering oversupply worries. By mid‑morning London time, Brent traded near US$64 and WTI near US$60, keeping pressure on oil‑linked equities heading into the next Gulf trading day. Reuters Adding to the
7 November 2025
··
Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining Company (NYSE: HL) is in focus today after reporting record third‑quarter results last night and hosting its earnings call this morning. The silver producer posted all‑time‑high quarterly revenue and net income, tightened 2025 production guidance, detailed permitting wins, and declared dividends on both common and preferred shares. Shares are trading sharply higher intraday amid the news. hecla2021rd.q4web.com+2 Key takeaways What drove the beat Management credited higher realized prices for silver and gold, increased sales volumes, and broad‑based operational execution. All operating assets generated positive free cash flow in the quarter. The company emphasized deleveraging progress — revolving credit
6 November 2025
···
B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold Corp. (NYSE American: BTG; TSX: BTO) entered Thursday with fresh third‑quarter results, confirmation that its flagship Fekola Complex in Mali continues to operate normally, a dividend declaration for Q4, and news that the Goose Mine in Nunavut achieved commercial production on October 2. The company kept full‑year production guidance for its core assets intact while trimming 2025 guidance at Goose as the ramp‑up progresses. B2Gold+1 Key takeaways What the numbers say B2Gold’s third‑quarter update highlights continued strength across its three operating mines (Fekola in Mali, Otjikoto in Namibia, and Masbate in the Philippines), supplemented by first ounces from Canada’s
6 November 2025
·
Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins Inc. (NYSE: CMI) delivered a stronger‑than‑expected third quarter, powered by surging demand for data‑center backup generation and solid service activity, even as North American truck markets softened. The company also raised its quarterly dividend and said it is conducting a strategic review of its electrolyzer business within the Accelera unit following non‑cash charges this quarter. Reuters+1 Market reaction As of 15:03 UTC today, CMI shares were up about 7.6% at $472.49, after earlier trading as high as $481.76. The rally followed the top‑ and adjusted bottom‑line beats and the dividend increase. (See live chart above.) By the numbers: Q3
6 November 2025
··
ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (COP) beats Q3, hikes dividend 8%, lifts 2025 output; Willow budget raised to up to $9B — Nov. 6, 2025

ConocoPhillips (NYSE: COP) delivered a news‑packed earnings day: the U.S. independent beat third‑quarter profit expectations, raised its full‑year production guidance, increased its quarterly dividend by 8% to $0.84, and updated the cost outlook for its Willow project in Alaska to $8.5–$9.0 billion. Management also released preliminary 2026 guidance with lower planned capital and operating costs and flat‑to‑modest production growth. ConocoPhillips The quick take By the numbers (Q3 2025) What changed today — and why it matters Earnings beat and stronger 2025 outlook. ConocoPhillips outpaced expectations on adjusted profit thanks to higher production and lower operating costs. The company also lifted
6 November 2025
···
AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

AT&T Stock 2025: 5G Ambitions, Big Dividend – Telecom Titan or Trap?

Company & Stock Overview AT&T Inc. is a telecom giant with a 140+ year legacy, now focused squarely on connectivity services. Its business model centers on providing voice and data communication to consumers and businesses via an expansive wireless network and a growing fiber-optic footprint. In the U.S. telecom market, AT&T operates alongside Verizon and T-Mobile in what analysts call a “durable triopoly”gurufocus.com – all three dominate market share, though each pursues a distinct strategy. AT&T’s aim is to be “America’s premier converged connectivity provider,” leveraging both high-speed 5G wireless and fiber broadband networksgurufocus.com. This dual network strategy is a
4 November 2025
·
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Real-Time Stock Price & Recent Performance As of November 4, 2025, Kimberly-Clark’s stock is trading around $102 per share, near its 52-week low. The current price reflects a dramatic sell-off that occurred on Monday, Nov 3, when KMB plunged from the high-$110s into the low $100s in a single sessionstockanalysis.com. Specifically, the stock collapsed -14.57% on Nov 3 to close at $102.27stockanalysis.com – an unusually large one-day move for a traditionally stable consumer staples stock. That wipeout followed an already soft October for the shares, which had hovered around $119-$120 in the prior weekchartmill.comchartmill.com. To put the recent action in
4 November 2025
··
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Stock Price and Recent Performance Pfizer’s stock has languished in 2025 despite a rising broader market. At ~$24.65, PFE is roughly flat since January and far below its 2021 peak (~$50)sharewise.com. In the past three years, the shares have tumbled about 50% as the company’s COVID-fueled revenue boom faded and investors braced for patent expirationssharewise.com. By mid-2025, Pfizer traded near multi-year lows (around $23), though it bounced off those lows in early October after positive news on earnings and policy. Notably, Pfizer’s stock surged ~15% at the end of Q3 (from ~$23.85 on Sept. 29 to ~$27.37 by Oct. 3statmuse.comstatmuse.com)
3 November 2025
·
Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Medical Properties Trust Defies Skeptics: Q3 Beat and Buyback Ignite 6%‑Yield REIT Rally

Q3 Earnings Surprise and Portfolio Updates Medical Properties Trust’s third-quarter results provided a dose of relief for investors who have endured a turbulent year. Normalized FFO came in at $0.13 per share, comfortably ahead of what many analysts had expected (consensus was near $0.08, with some forecasts as low as essentially breakeven)chartmill.com. This key profit metric for REITs was down from $0.16 a year agobusinesswire.com, reflecting ongoing challenges, but the “beat” versus expectations drew focus. “Investors responded positively to the earnings beat and management’s optimistic commentary,” noted ChartMill, after MPW shares rose about 2–3% in pre-market trading on the reportchartmill.com.
30 October 2025
·
Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

Altria Stock Slips After Mixed Q3 Earnings – Big Buyback and 8% Dividend Tempt Investors

MO Stock Slides on Mixed Earnings Altria’s third-quarter earnings highlight the tobacco giant’s balancing act between resilient profits and declining cigarette usage. The company reported an adjusted Q3 profit of $1.45 per share, a 3.6% increase year-on-year and exactly in line with analyst expectations reuters.com. However, revenue fell more than anticipated – net revenues came in at $6.07 billion, down ~3% from a year ago reuters.com. This topline drop exceeded Wall Street’s forecasts and underscored weaker cigarette volumes. The mixed results put immediate pressure on MO stock, which fell about 4% ahead of Thursday’s open on the news reuters.com. Even after
30 October 2025
··
Coal India Profit Plunges 31% Despite Big Dividend; L&T, Varun Beverages Ride Q2 Earnings Wave

Coal India Profit Plunges 31% Despite Big Dividend; L&T, Varun Beverages Ride Q2 Earnings Wave

In-Depth: Q2 Earnings Highlights and Market Impact India’s earnings season reached a crescendo on October 29, with over 65 companies declaring quarterly resultsbusiness-standard.com. Two heavyweights, Coal India and L&T, were in the spotlight – one for a profit slump, the other for expected resilience – and their announcements did not disappoint in drawing market reactions. Coal India: Profit Plunge and a Sweetener for Shareholders Coal India, the world’s largest coal producer, reported a steep fall in profit as higher costs and softer coal prices eroded its bottom line. Consolidated net profit for Q2 FY26 fell to ₹4,262–4,354 crore, a ~30–32%
29 October 2025
·
UPS Delivers Earnings Surprise as Stock Soars – But Will Its 7.5% Dividend Survive?

UPS Delivers Earnings Surprise as Stock Soars – But Will Its 7.5% Dividend Survive?

Earnings Beat Sparks Relief Rally UPS delivered a much-needed positive surprise in its third-quarter earnings, giving weary investors a jolt of optimism. The Atlanta-based logistics giant reported $1.31 billion in net income for Q3, or $1.55 per share (GAAP), and $1.74 per share after one-time costs seattlepi.com. Both earnings and revenue comfortably beat analyst estimates seattlepi.com seattlepi.com, which had predicted a steep year-over-year profit drop amid soft package volumes. In fact, EPS had been expected to plunge ~25% versus last year nasdaq.com, so UPS’s performance suggests it managed costs and pricing far better than anticipated. Wall Street reacted swiftly. In pre-market
28 October 2025
·
1 … 30 31 32 33

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop